Stock Price

Radian has bet its future on a massive strategic pivot. New CEO Mike Weinbach brings a mortgage tech playbook to a complex global insurance game. Will it work?

Mobilewalla plans to go public as Covariate via a SPAC, touting its vertical AI. But a troubled SPAC market and a history of data privacy issues loom large.

A biotech's new funding offers a glimmer of hope for a novel cancer therapy, but a look at the books reveals a desperate race against time and capital.

Two Harbors fires back at a "baseless" lawsuit from UWM, exposing a financial firestorm centered on a massive derivatives loss and a failed merger.

With a NYSE delisting notice and a dividend under scrutiny, Lument Finance Trust's Q2 report is more than just numbers—it's a test of its strategy.

uCloudlink's stock is below $1, triggering a Nasdaq delisting threat. Is this a market blip or a fatal sign that its 'data sharing' dream is fading?

The chip designer just secured a massive, interest-free capital infusion. We decode the savvy deal structure and what it means for its AI ambitions.

Wah Fu Education's stock soared after announcing a radical pivot to enterprise AI. But can custom models for agriculture and medicine save a struggling company?

AGCO's stock plunged after a surprise guidance cut, triggering a legal probe. We dissect if this was just a market downturn or a failure in transparency.

Christopher Nolan's 'The Odyssey' has become IMAX's biggest film ever, driving record profits and showcasing groundbreaking camera technology.

Braveheart Bio's stunning IPO debut raised nearly half a billion dollars. We dig into the story behind the numbers and what it signals for the 2026 economy.

BitFuFu sold millions in Bitcoin to fund a massive operational expansion, a risky gamble that has left investors wary and the industry watching closely.

With two strategic board appointments, junior miner Skull Ridge Gold signals a major push to unlock its flagship project amid Newfoundland's gold rush.

With a $250M decision pending and a major acquisition closing, Zymeworks is betting its future on a radical pivot to a diversified, revenue-generating model.

The iconic Canadian jeweler is delisting from the NYSE American. We dig into the financial pressures and strategic calculus behind this pivotal move.

Amid a booming Alberta energy sector, AKITA Drilling launches a major share buyback, signaling deep confidence in its value while balancing debt reduction.

As Birchtech preps for its Q2 earnings, the market is watching. Its PFAS-fighting tech is promising, but can it fix a battered stock and prove its path to profit?

Onfolio Holdings is betting on a 1-for-50 reverse split to save its Nasdaq listing. But is it a lifeline or a red flag for a company facing deeper issues?

RECONOVA's massively oversubscribed IPO met a cool reception on its first day, signaling a new era where AI firms must prove profitability, not just potential.

With a massive C$150M financing, Snowline Gold isn't just funding a mine; it's underwriting a new gold district in a high-stakes, supply-constrained market.